Ronald G Leonerdi Dr entered the industry of Commercial Medical Research in 1999 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Ronald G Leonerdi by calling (858) 586-0751 during business hours. You can also write to the business’ Single Location at 9915 Caminito Chirimolla, San Diego, California CA 92131. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Ronald G Leonerdi Dr |
Representative: | Ronald G Leonerdi |
Place of Business: | 9915 Caminito Chirimolla, San Diego, CA 92131 |
Contact Number: | (858) 586-0751 |
Type of Service: | Commercial Medical Research |
SIC Number: | 8731 |
NAICS Number: | 541712 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 1999 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Ronald G Leonerdi Dr is a company operating from San Diego, California providing professional Commercial Medical Research and relevant B2B variables. It was founded in 1999 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.
With a current employee count of 1 to 4, Ronald G Leonerdi Dr has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Ronald G Leonerdi at (858) 586-0751 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 9915 Caminito Chirimolla in San Diego, California 92131 and can be engaged online through the company website at , the company Twitter , and Facebook page .